Search tips
Search criteria 


Logo of bmjcrInstructions for authorsCurrent ToCBMJ Case Reports
BMJ Case Rep. 2010; 2010: bcr0220102760.
Published online Aug 24, 2010. doi:  10.1136/bcr.02.2010.2760
PMCID: PMC3029827
Rare disease
Cardiac involvement in Anderson–Fabry disease
Filippo Maria Cauti,1 Constantinos O'Mahony,2 and Antonis Pantazis2
1Cardiology Department, University of Rome ‘Sapienza’, Via di Grottarossa, Rome, Italy
2Inherited Cardiac Diseases Unit, The Heart Hospital, London, UK
Correspondence to Filippo Maria Cauti, filippocauti/at/
A normotensive 50-year-old man was evaluated for cardiac symptoms associated with left ventricular hypertrophy (LFH). His symptoms were caused by cardiac involvement from Anderson–Fabry disease (AFD), an X linked lysosomal storage disease caused by mutations in the GLA gene which encodes for the lysosomal enzyme -galactosidase A. He was treated with recombinant enzyme but the clinical course was complicated by arrhythmias and the patient required an internal cardioverter defibrillator.
Even though AFD is rare, this case illustrates the importance of considering the diagnosis in selected patients as effective treatment has recently become available. Recognition of AFD also allows for screening of asymptomatic relatives who may benefit from treatment before irreversible life-threatening complications develop.
Articles from BMJ Case Reports are provided here courtesy of
BMJ Group